Literature DB >> 19182089

Resident-based acute stroke protocol is expeditious and safe.

Andria L Ford1, Lisa Tabor Connor, David K Tan, Jennifer A Williams, Jin-Moo Lee, Abdullah M Nassief.   

Abstract

BACKGROUND AND
PURPOSE: The decision to administer tPA to acute stroke patients is frequently made by stroke attendings or fellows, but placing residents in this position may make tPA delivery more efficient.
METHODS: Beginning in 2004, we instituted a resident-based acute stroke protocol placing neurology residents in decision-making roles. Time-intervals, symptomatic hemorrhage rate, and discharge locations were prospectively collected and compared between two epochs, before and after 2004.
RESULTS: 59 acute ischemic stroke patients were treated with tPA before protocol initiation (1998 to 2002), while 113 patients were treated after protocol initiation (2004 to 2007). The average door-to-needle and onset-to-needle times were significantly shorter after initiation of the resident-based protocol (81 versus 60 minutes [P<0.001] and 138 versus 126 minutes [P<0.05]), respectively. Symptomatic hemorrhage rate (5.1% versus 3.5%) and favorable discharge location (68% versus 76%) did not differ between the two time periods.
CONCLUSIONS: A resident-driven tPA protocol, with formal training and quality control, is safe and efficient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182089      PMCID: PMC2729544          DOI: 10.1161/STROKEAHA.108.527770

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Authors:  G W Albers; V E Bates; W M Clark; R Bell; P Verro; S A Hamilton
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

2.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

3.  Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.

Authors:  R W Smith; P A Scott; R J Grant; C R Chudnofsky; S M Frederiksen
Journal:  Acad Emerg Med       Date:  1999-06       Impact factor: 3.451

4.  Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.

Authors:  J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 5.  Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

Authors:  M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker
Journal:  JAMA       Date:  2000-06-21       Impact factor: 56.272

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.

Authors:  Jan Sobesky; Monika Frackowiak; Olivier Zaro Weber; Moritz Hahn; Walter Möller-Hartmann; Jobst Rudolf; Michael Neveling; Martin Grond; Susanne Schmulling; Andreas Jacobs; Wolf-Dieter Heiss
Journal:  Cerebrovasc Dis       Date:  2007-05-22       Impact factor: 2.762

8.  Determining intravenous rt-PA eligibility in the Emergency Department.

Authors:  Amy C Mecozzi; Devin L Brown; Lynda D Lisabeth; William G Barsan; Robert Silbergleit; Susan L Hickenbottom; Phillip A Scott; Lewis B Morgenstern
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

  8 in total
  4 in total

1.  Accuracy of emergency medical services-reported last known normal times in patients suspected with acute stroke.

Authors:  David Curfman; Lisa Tabor Connor; Hawnwan Philip Moy; Laura Heitsch; Peter Panagos; Jin-Moo Lee; David K Tan; Andria L Ford
Journal:  Stroke       Date:  2014-03-18       Impact factor: 7.914

2.  Door-to-Needle Time in Acute Stroke Treatment and the "July Effect".

Authors:  Maximiliano A Hawkes; Federico Carpani; Mauricio F Farez; Sebastian F Ameriso
Journal:  Neurohospitalist       Date:  2017-09-27

Review 3.  A resident boot camp for reducing door-to-needle times at academic medical centers.

Authors:  Ilana M Ruff; Ava L Liberman; Fan Z Caprio; Matthew B Maas; Scott J Mendelson; Farzaneh A Sorond; Deborah Bergman; Richard A Bernstein; Yvonne Curran; Shyam Prabhakaran
Journal:  Neurol Clin Pract       Date:  2017-06

4.  Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes.

Authors:  Marco Gonzalez-Castellon; Christine Ju; Ying Xian; Adrian Hernandez; Gregg C Fonarow; Lee Schwamm; Eric E Smith; Deepak L Bhatt; Matthew Reeves; Joshua Z Willey
Journal:  J Am Heart Assoc       Date:  2018-01-31       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.